Загрузка...
Toxin-Specific Antibodies for the Treatment of Clostridium difficile: Current Status and Future Perspectives (†)
Therapeutic agents targeting bacterial virulence factors are gaining interest as non-antibiotic alternatives for the treatment of infectious diseases. Clostridium difficile is a Gram-positive pathogen that produces two primary virulence factors, enterotoxins A and B (TcdA and TcdB), which are respon...
Сохранить в:
| Главные авторы: | , |
|---|---|
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
MDPI
2010
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3153223/ https://ncbi.nlm.nih.gov/pubmed/22069622 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/toxins2050998 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|